G9a - An Appealing Antineoplastic Target

E-ISSN： 1873-5576|17|6|555-568

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.6, 2017-06, pp. : 555-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Cycle as a Target of Antineoplastic Drugs

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1417-1426

Bentham Science Publishers

Access to resources Recommend Favorite

Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy

Current Medicinal Chemistry, Vol. 12, Iss. 11, 2005-06 ,pp. : 1283-1294

Bentham Science Publishers

Access to resources Recommend Favorite

Tubulin: A Target for Antineoplastic Drugs into the Cancer Cells but also in the Peripheral Nervous System

Current Medicinal Chemistry, Vol. 16, Iss. 11, 2009-04 ,pp. : 1315-1324

Bentham Science Publishers

Access to resources Recommend Favorite

PCSK9: an emerging target for treatment of hypercholesterolemia

By Duff Christopher J Hooper Nigel M

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 157-168

Informa Healthcare

Access to resources Recommend Favorite

ADAM9 as a Potential Target Molecule in Cancer

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2282-2287

Bentham Science Publishers

Access to resources Recommend Favorite